There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Matsuo et al (1992) Effct of an intestinal disccharidase inhibitor (AO-128) on obesity and diabetes, Am,Jclin,Nutr, 55 314S, Matsui et al (2009) a-Glcosidase inhibition assay in an enzyme-immobilized amino-mcroplate, Anal,ci, 25 559, Moritoh et al (2009)chronc administration of voglibose; an a-glcosidase inhibitor; icreases ctive glcagon-like peptide-1 levels by icreasing its scretion and dcreasing dipeptidyl peptidase-4 ctivity in ob/ob mce, J,Pharmcol,Exp,Ther, 329 669,"
"Voglibose is a valiolamine derivative and inhibitor of alpha-glucosidase with antihyperglycemic activity. Voglibose binds to and inhibits alpha-glucosidase, an enteric enzyme found in the brush border of the small intestines that hydrolyzes oligosaccharid"
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Overview
"Voglibose is a valiolamine derivative and inhibitor of alpha-glucosidase with antihyperglycemic activity. Voglibose binds to and inhibits alpha-glucosidase, an enteric enzyme found in the brush border of the small intestines that hydrolyzes oligosaccharid"
